Concepedia

Quanyun A. Xu

QA

Statistics

Publications

17

Citations

1.6K

H-Index

13

Active since

1994

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Texas Southern University

The University of Texas at Austin

Quanyun A. Xu is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, pharmacy, and pharmaceutical stability.

Publications per year

1994–2023

17

Publications

17

An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Jennifer R. Molina, Yuting Sun, Marina Protopopova et al. · Nature Medicine · 2018 · 951 citations · Full text

, , +14

Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials

Timothy A. Yap, Naval Daver, Mikhila Mahendra et al. · Nature Medicine · 2023 · 377 citations

, , +14

Phase I trial of IACS-010759 (IACS), a potent, selective inhibitor of complex I of the mitochondrial electron transport chain, in patients (pts) with advanced solid tumors.

Timothy A. Yap, Sarina A. Piha‐Paul, Siqing Fu et al. · Journal of Clinical Oncology · 2019 · 70 citations

, , +12

Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma

Michael A. Davies, Patricia S. Fox, Nicholas E. Papadopoulos et al. · Clinical Cancer Research · 2012 · 52 citations · Full text

, , +17

Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32°C

Quanyun A. Xu, Lawrence A. Trissel, Juan F. Martinez · American Journal of Health-System Pharmacy · 1994 · 28 citations

, , +8

1–5 of 17